Abridge vs iCAD (DeepHealth)

Abridge is a clinical documentation AI that listens to doctor-patient conversations and generates structured clinical notes in real time — attacking one of medicine's biggest burnout drivers: hours of paperwork after every shift.

During a visit, Abridge's ambient AI captures the conversation and converts it into a draft note in proper clinical structure, mapping spoken discussion to medical terminology and coding requirements, with links back to the source audio so clinicians can verify anything. It integrates directly into major EHR systems (notably Epic), so notes land where the workflow already lives, and supports multiple languages for diverse patient populations.

It's enterprise h…

iCAD develops AI-powered breast health solutions that help radiologists improve the early detection of breast cancer. Its ProFound Breast Health Suite uses deep learning to analyze mammograms, assess breast density, and identify suspicious findings. The platform is designed to increase diagnostic accuracy, reduce reading times, and optimize radiology workflows. iCAD solutions integrate with existing PACS and imaging systems and are used by hospitals, imaging centers, and breast screening programs worldwide. In 2025, iCAD was acquired by DeepHealth, a RadNet subsidiary, expanding DeepHealth's portfolio of AI-driven imaging technologies while retaining the iCAD brand.